EGF stimulates Müller glial proliferation via a BMP-dependent mechanism

Yumi Ueki1, Thomas A Reh

  • 1Department of Biological Structure, University of Washington, Seattle, Washington 98195, USA.

Glia
|January 31, 2013
PubMed

Insights

Epidermal Growth Factor (EGF) stimulates Müller glial proliferation in mouse retinas via MEK/ERK1/2 and PI3K/AKT pathways. Bone Morphogenetic Protein (BMP)/Smad1/5/8 signaling, partly autocrine, is also crucial for this glial response.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Ophthalmology

Background:

  • Müller glia are the primary glial cells in the retina, normally quiescent but capable of proliferation under pathological conditions.
  • Epidermal Growth Factor (EGF) is a known mitogen for Müller glia, but the underlying signaling mechanisms remain unclear.
  • Understanding glial proliferation is vital for addressing retinal diseases and regeneration.

Purpose of the Study:

  • To elucidate the signaling pathways involved in EGF-induced Müller glial proliferation.
  • To investigate the role of Bone Morphogenetic Protein (BMP)/Smad signaling in this process.
  • To explore potential autocrine mechanisms regulating Müller glial proliferation.

Main Methods:

  • Explants of postnatal day 12 (P12) or adult trp53(-/-) mouse retinas were cultured with EGF.
  • Signaling pathway inhibitors (MEK/ERK1/2, PI3K/AKT, BMP) were used to assess their necessity for proliferation.
  • Dissociated Müller glial cultures were treated with EGF and BMP inhibitors to study autocrine signaling.

Main Results:

  • EGF-induced Müller glial proliferation requires the activation of both MEK/ERK1/2 and PI3K/AKT pathways.
  • Activation of BMP/Smad1/5/8 signaling, downstream of PI3K/AKT, is essential for robust proliferation.
  • EGF treatment upregulates Bmp7 in Müller glia, suggesting an autocrine BMP/Smad1/5/8 signaling component.

Conclusions:

  • EGF stimulates Müller glial proliferation through a complex signaling cascade involving MEK/ERK1/2, PI3K/AKT, and BMP/Smad1/5/8 pathways.
  • Autocrine BMP signaling plays a significant role in EGF-mediated Müller glial proliferation.
  • These findings offer insights into retinal proliferative disorders and regeneration strategies.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...